Citius Oncology, Inc. (CTOR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 29.42M | 37.15M | 27.54M | 18.31M | 18.04M | 17.08M | 10.97M | 10.01M | 8.91M | 7.73M | 7.73M | 377.34K |
| Cash & Short-Term Investments | 2.63M | 7.3M | 3.92M | 112 | 112 | 112 | 112 | 0 | 0 | 0 | 0 | 289.18K |
| Cash Only | 2.63M | 7.3M | 3.92M | 112 | 112 | 112 | 112 | 0 | 0 | 0 | 0 | 289.18K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.08M | 4.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 138.41 | 94.45 | - | - | - | - | - | - | - | - | - | - |
| Inventory | 22.66M | 22.64M | 22.29M | 17.21M | 15.34M | 14.38M | 8.27M | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 6.2K | 2.62K | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 71.28M | 72.83M | 73.4M | 73.4M | 73.4M | 73.4M | 73.4M | 40M | 40M | 40M | 40M | 67.81M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 71.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67.81M |
| Other Non-Current Assets | 169.25K | 72.83M | 73.4M | 73.4M | 73.4M | 73.4M | 73.4M | 40M | 40M | 40M | 40M | 0 |
| Total Assets | 100.7M | 109.97M | 100.94M | 91.71M | 91.44M | 90.48M | 84.37M | 50.01M | 48.91M | 47.73M | 47.73M | 68.19M |
| Asset Turnover | 0.02x | 0.04x | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 10.13% | 21.54% | 19.64% | 83.39% | 86.97% | 89.55% | 76.74% | - | - | - | - | - |
| Total Current Liabilities | 58.81M | 44.71M | 49.49M | 52.99M | 49.74M | 43.4M | 32.7M | 31.39M | 27.62M | 23.71M | 21.05M | 31.84K |
| Accounts Payable | 8.88M | 10.45M | 13.23M | 8.67M | 7.68M | 5.87M | 3.71M | 0 | 503.91K | 205.02K | 1.29M | 0 |
| Days Payables Outstanding | 2.64K | 1.38K | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 25.87M | 18.25M | 22.65M | 28.4M | 28.4M | 28.4M | 28.4M | 0 | 0 | 0 | 0 | 31.84K |
| Current Ratio | 0.50x | 0.83x | 0.56x | 0.35x | 0.36x | 0.39x | 0.34x | 0.32x | 0.32x | 0.33x | 0.37x | 11.85x |
| Quick Ratio | 0.12x | 0.32x | 0.11x | 0.02x | 0.05x | 0.06x | 0.08x | 0.32x | 0.32x | 0.33x | 0.37x | 11.85x |
| Cash Conversion Cycle | 3.69K | 1.33K | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 6.62M | 6.85M | 6.59M | 6.32M | 6.06M | 5.79M | 5.53M | 1.58M | 1.44M | 1.3M | 1.15M | 0 |
| Long-Term Debt | 3.8M | 3.8M | 3.8M | 3.8M | 3.8M | 3.8M | 3.8M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 2.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 3.05M | 2.78M | 2.52M | 2.26M | 1.99M | 1.73M | 1.58M | 1.44M | 1.3M | 1.15M | 0 |
| Total Liabilities | 65.43M | 51.56M | 56.08M | 59.31M | 55.8M | 49.19M | 38.23M | 32.98M | 29.06M | 25.01M | 22.2M | 31.84K |
| Total Debt | 3.8M | 3.8M | 3.8M | 3.8M | 3.8M | 3.8M | 3.8M | 0 | 0 | 0 | 0 | 0 |
| Net Debt | 1.17M | -3.5M | -124.8K | 3.8M | 3.8M | 3.8M | 3.8M | 0 | 0 | 0 | 0 | -289.18K |
| Debt / Equity | 0.11x | 0.07x | 0.08x | 0.12x | 0.11x | 0.09x | 0.08x | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | -0.76x |
| Interest Coverage | -866.26x | -113.96x | -81.62x | -30.76x | - | - | - | - | - | - | - | - |
| Total Equity | 35.27M | 58.41M | 44.87M | 32.4M | 35.64M | 41.29M | 46.14M | 17.03M | 19.85M | 22.73M | 25.54M | 68.16M |
| Equity Growth % | -1.05% | 41.47% | -2.76% | 90.23% | 79.59% | 81.69% | 80.69% | - | - | - | - | - |
| Book Value per Share | 0.35 | 0.67 | 0.55 | 0.45 | 0.50 | 0.58 | 0.64 | 0.26 | 0.30 | 0.25 | 0.29 | 0.76 |
| Total Shareholders' Equity | 35.27M | 58.41M | 44.87M | 32.4M | 35.64M | 41.29M | 46.14M | 17.03M | 19.85M | 22.73M | 25.54M | 68.16M |
| Common Stock | 9.3K | 8.48K | 8.35K | 7.16K | 7.16K | 7.16K | 7.16K | 6.75K | 6.75K | 6.75K | 6.75K | 242 |
| Retained Earnings | -96.18M | -69.57M | -64.04M | -59.04M | -53.67M | -45.94M | -39.28M | -32.47M | -27.69M | -22.86M | -18.13M | 345.27K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |